Judith Hartmann
Chief Financial Officer and Member of the Board of ManagementBayer
PharmaceuticalsView Profile →Executive Director and CFO · AstraZeneca
Aradhana Sarin is AstraZeneca’s chief financial officer and an executive director. She moved into biopharmaceutical leadership at Alexion after a career combining medical practice and healthcare investment banking.
Last reviewed: Nov 16, 2026
Aradhana Sarin is AstraZeneca’s chief financial officer and an executive director. She moved into biopharmaceutical leadership at Alexion after a career combining medical practice and healthcare investment banking.
Sarin trained in medicine at the University of Delhi and spent two years treating patients in India and Africa. She subsequently completed an MBA at Stanford before entering healthcare investment banking.
Her early banking work included transaction execution in JPMorgan’s mergers-and-acquisitions advisory and healthcare groups. She later became a managing director in healthcare investment banking at UBS. From 2010 to 2017 she worked at Citi Global Banking, ultimately as managing director of Healthcare Corporate and Investment Banking, serving life-sciences and biopharmaceutical clients.
She joined Alexion in November 2017 as senior vice president for Business Development and Corporate Strategy. In February 2019 she became executive vice president, chief strategy and business officer and chief of staff to the CEO. Her responsibilities brought healthcare-sector transaction experience into the operating company’s strategy and business-development work.
In October 2019, Sarin became Alexion’s chief financial officer. The change followed the September board decision and the filing of its third-quarter report. She also served on OraSure Technologies’ board from 2018 to 2020, choosing not to seek re-election as she focused on her Alexion responsibilities.
Following AstraZeneca’s acquisition of Alexion, Sarin joined AstraZeneca’s board as CFO in August 2021. Her move combined prior clinical practice, healthcare banking, corporate strategy and finance leadership. In July 2023, the American Red Cross elected her to its national Board of Governors.
Master of Business Administration — Stanford Graduate School of Business.
University of Delhi — Medicine.